Sirolimus in Liver Transplant Recipients With Hepatocellular Carcinoma

Sirolimus in Liver Transplant Recipients With Hepatocellular Carcinoma

Bibliographic Details
Main Authors:	Sam Grigg, Paul Gow, Neville Yeomans
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2020-04-01
Series:	Journal of Investigative Surgery
Online Access:	http://dx.doi.org/10.1080/08941939.2018.1513103

Similar Items

Sirolimus in Liver Transplant Recipients with Hepatocellular Carcinoma: An Updated Meta-Analysis
by: Zhi-Hua Zhang, et al.
Published: (2019-10-01)

Autophagy in kidney transplants of sirolimus treated recipients
by: Sagar Bhayana, et al.
Published: (2017-04-01)

Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma
by: Koen G. A. M. Hussaarts, et al.
Published: (2021-01-01)

Use of Adjuvant Sorafenib in Liver Transplant Recipients with High-Risk Hepatocellular Carcinoma
by: Kirti Shetty, et al.
Published: (2014-01-01)

Coadministration of isavuconazole and sirolimus in allogeneic hematopoietic stem cell transplant recipients
by: Francesca Farina, et al.
Published: (2024-09-01)

Dosing Regimen Recommendations for Sirolimus in Adult Liver Transplant Recipients: Insights from a Population Pharmacokinetic Model
by: Mao J, et al.
Published: (2024-12-01)

Sirolimus in combination with low-dose extended-release tacrolimus in kidney transplant recipients
by: Zhi-yu Zou, et al.
Published: (2023-12-01)

Conversion to Sirolimus Therapy in Kidney Transplant Recipients with New Onset Diabetes Mellitus after Transplantation
by: Massimiliano Veroux, et al.
Published: (2013-01-01)

Case report: Pharmacokinetic interaction involving sirolimus and regorafenib in patients with post-transplant recurrent hepatocellular carcinoma
by: Kongcai Zhu, et al.
Published: (2025-02-01)

Impact of Sirolimus versus Mycophenolate Mofetil on Kidney Function after Calcineurin Inhibitor Dose Reduction in Liver Transplant Recipients
by: Heng-Yi Chiang, et al.
Published: (2023-07-01)

Conversion to sirolimus in kidney transplant recipients with squamous cell cancer and changes in immune phenotype.
by: Carroll, R, et al.
Published: (2013)

The Impact of Sirolimus on hepatitis C Recurrence after Liver Transplantation
by: Sonal Asthana, et al.
Published: (2011-01-01)

An E2F7/TSC1-based model for predicting the efficacy of sirolimus after liver transplantation for hepatocellular carcinoma beyond the Milan criteria
by: Lincheng Zhang, et al.
Published: (2024-08-01)

Liver transplantation for advanced hepatocellular carcinoma
by: Hae Won Lee, et al.
Published: (2016-09-01)

“No-Touch” Left Approach for Recipient Hepatectomy: A Promising Strategy to Minimize Hepatocellular Carcinoma Recurrence in Liver Transplantation
by: Shiwei Yang, MD, et al.
Published: (2024-06-01)

The Benefit of Sirolimus Maintenance Immunosuppression and Rabbit Antithymocyte Globulin Induction in Liver Transplant Recipients That Develop Acute Kidney Injury in the Early Postoperative Period
by: Benjamin T. Duhart, et al.
Published: (2015-01-01)

Thrombosis after liver transplantation for hepatocellular carcinoma.
by: Ida Martinelli, et al.
Published: (2017-01-01)

The Perioperatively Altered Neutrophil-to-Lymphocyte Ratio Associates with Impaired DNA Damage Response in Liver Transplantation Recipients with Hepatocellular Carcinoma
by: Kuang-Den Chen, et al.
Published: (2021-01-01)

Recipient hepatectomy under total hepatic vascular exclusion to prevent hepatocellular carcinoma spread in living donor liver transplantation
by: Young-In Yoon, et al.
Published: (2021-06-01)

Use of sirolimus as an adjuvant therapy for kidney transplant recipients with high-risk cutaneous squamous cell carcinomas: a prospective non-randomized controlled study
by: Marina Rezende de Fázio, et al.
Published: (2023-08-01)

Long-term results of liver transplantation for hepatocellular carcinoma
by: M. Sh. Khubutia, et al.
Published: (2018-08-01)

Expanding Indications for Liver Transplantation in the Treatment of Hepatocellular Carcinoma
by: Rachel Hogen, et al.
Published: (2024-08-01)

Imaging of hepatocellular carcinoma recurrence after liver transplantation
by: Giuseppe Mamone, et al.
Published: (2023-05-01)

Management of hepatocellular carcinoma recurrence after liver transplantation
by: Parul D. Agarwal, et al.
Published: (2022-01-01)

Liver Transplantation in the Treatment of Unresectable Hepatocellular Carcinoma in the Absence of Liver Cirrhosis
by: O. D. Olisov, et al.
Published: (2018-09-01)

Sirolimus-induced bronchiolitis obliterans organizing pneumonia in a kidney transplant recipient; a case report and review of literature
by: Behzad Einollahi, et al.
Published: (2014-07-01)

Trial protocol for SiroSkin: a randomised double-blind placebo-controlled trial of topical sirolimus in chemoprevention of facial squamous cell carcinomas in solid organ transplant recipients
by: Lea Dousset, et al.
Published: (2024-11-01)

Oral Cavity Metastasis of Hepatocellular Carcinoma following Liver Transplantation
by: Nicolás Goldaracena, et al.
Published: (2012-01-01)

The stratifying value of Hangzhou criteria in liver transplantation for hepatocellular carcinoma.
by: Jun Chen, et al.
Published: (2014-01-01)

New prognostic model for liver transplantation outcomes in hepatocellular carcinoma
by: S. E. Voskanyan, et al.
Published: (2024-09-01)

Thyroid Metastases from Hepatocellular Carcinoma after Liver Transplantation
by: Danilo Dias Avancini Viana, et al.
Published: (2024-10-01)

Bridge Therapy before Liver Transplant for Advanced Hepatocellular Carcinoma
by: Valentina Bianchi, et al.
Published: (2024-06-01)

Hepatocellular Carcinoma: Optimal Radiological Evaluation before Liver Transplantation
by: Marco Dioguardi Burgio, et al.
Published: (2023-11-01)

Immunotherapy Use Prior to Liver Transplant in Patients with Hepatocellular Carcinoma
by: Stephanie M. Woo, et al.
Published: (2022-12-01)

Immunotherapy for hepatocellular carcinoma in liver transplant patients (Literature review)
by: I. A. Dzhanyan, et al.
Published: (2023-09-01)

Enhanced recovery after liver transplantation for patients with hepatocellular carcinoma
by: TONG Hui, CHEN Peng, ZHANG Jiaqiang, XIE Junjie, LI Tao, ZHU Zhecheng, PENG Chenghong
Published: (2020-01-01)

Fungal Infections in Liver Transplant Recipients
by: Michael Scolarici, et al.
Published: (2021-06-01)

Racial and Ethnic Differences in Liver Transplantation and Post–Liver Transplant Survival Among Patients With Hepatocellular Carcinoma
by: Udhayvir S. Grewal, et al.
Published: (2024-11-01)

Utilization of hepatitis B surface antigen-positive donors in liver transplantation for recipients with hepatocellular carcinoma: a retrospective and propensity score matching analysis
by: Zhitao Chen, et al.
Published: (2023-07-01)

Lung Transplantation Outcomes and Peritransplant Sirolimus Use in Lymphangioleiomyomatosis
by: Emily L. Larson, BS, et al.
Published: (2025-03-01)